Equities Analysts Issue Forecasts for SPRY FY2028 Earnings
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Research analysts at Leerink Partnrs dropped their FY2028 EPS estimates for ARS Pharmaceuticals in a research note issued to investors on Thursday, March 20th. Leerink Partnrs analyst R. Ruiz now anticipates that the company will post earnings of $1.57 per share for the year, down from their […]
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Research analysts at Leerink Partnrs dropped their FY2028 EPS estimates for ARS Pharmaceuticals in a research note issued to investors on Thursday, March 20th. Leerink Partnrs analyst R. Ruiz now anticipates that the company will post earnings of $1.57 per share for the year, down from their […]
